Media Center

Recent News

05/09/17ACADIA Pharmaceuticals Reports First Quarter 2017 Financial ResultsPrinter Friendly Version
05/08/17ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference on May 16, 2017Printer Friendly Version
05/02/17ACADIA Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 9, 2017Printer Friendly Version
03/30/17ACADIA Pharmaceuticals Announces Appointment of Michael J. Yang as Executive Vice President, Chief Commercial OfficerPrinter Friendly Version
03/29/17ACADIA Pharmaceuticals to Present at Needham & Company’s 16th Annual Healthcare Conference on April 5, 2017Printer Friendly Version
2017 | 2016 | 2015 | Archive

Company Information

Annual Report
Corporate Presentation


Scientific Publications

Pimavanserin for patients with Parkinson's disease psychosis: a randomized, placebo-controlled phase 3 trial. The Lancet, 383, 533-540 (2014).